Long non-coding RNA HULC exerts oncogenic activity on papillary thyroid cancer in vitro and in vivo
AbstractThyroid cancer is a frequently happened malignancy in human endocrine system. Papillary thyroid cancer (PTC) presents 70–80% of all thyroid cancer cases. Herein, we probed the possible oncogenic function of long non-coding RNA (lncRNA) highly up-regulated in liver cancer (HULC) in PTC. First...
Main Authors: | Zhijia Yang, Guoqing Li, Chao Ding, Wencong Sun, Ji Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Artificial Cells, Nanomedicine, and Biotechnology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1703730 |
Similar Items
-
Regulatory Mechanisms of lncRNAs and Their Target Gene Signaling Pathways in Laryngeal Squamous Cell Carcinoma
by: Wei Li, et al.
Published: (2020-07-01) -
A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer
by: Ting Deng, et al.
Published: (2023-03-01) -
Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto’s thyroiditis
by: Yuepeng Zhang, et al.
Published: (2022-10-01) -
Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway
by: Tong Bu, et al.
Published: (2023-09-01) -
Long Noncoding RNA DANCR Activates Wnt/β-Catenin Signaling through MiR-216a Inhibition in Non-Small Cell Lung Cancer
by: Justine E. Yu, et al.
Published: (2020-12-01)